300122 智飞生物
开盘竞价 11-06 09:30:00
资讯
新帖
简况
智飞生物（300122）披露回购公司股份进展公告，11月03日股价上涨4.97%
证券之星 · 11-03 18:57
智飞生物（300122）披露回购公司股份进展公告，11月03日股价上涨4.97%
股市必读：智飞生物（300122）10月30日董秘有最新回复
证券之星 · 11-02
股市必读：智飞生物（300122）10月30日董秘有最新回复
智飞生物：截至2026年10月20日，公司普通股股东人数为118,679
证券之星 · 10-30
智飞生物：截至2026年10月20日，公司普通股股东人数为118,679
智飞生物：公司员工持股计划正常存续中
证券之星 · 10-30
智飞生物：公司员工持股计划正常存续中
智飞生物（300122）10月28日主力资金净卖出2643.16万元
证券之星 · 10-29
智飞生物（300122）10月28日主力资金净卖出2643.16万元
智飞生物（300122）2026年三季报简析：亏损收窄，盈利能力上升
证券之星 · 10-28
智飞生物（300122）2026年三季报简析：亏损收窄，盈利能力上升
智飞生物（300122）10月27日主力资金净买入1731.82万元
证券之星 · 10-28
智飞生物（300122）10月27日主力资金净买入1731.82万元
智飞生物(300122)10月9日股东户数12.32万户，较上期减少0.63%
证券之星 · 10-27
智飞生物(300122)10月9日股东户数12.32万户，较上期减少0.63%
智飞生物最新公告：冻干人用狂犬病疫苗获药品注册证书
证券之星 · 10-27
智飞生物最新公告：冻干人用狂犬病疫苗获药品注册证书
智飞生物(300122.SZ)发布前三季度业绩，归母净亏损6.83亿元
智通财经网 · 10-27
智飞生物(300122.SZ)发布前三季度业绩，归母净亏损6.83亿元
智飞生物：Q3净利1.25亿元，同比增117.36%
格隆汇 · 10-26
智飞生物：Q3净利1.25亿元，同比增117.36%
智飞生物最新公告：第三季度净利润1.25亿元同比增长117.36%
证券之星 · 10-26
智飞生物最新公告：第三季度净利润1.25亿元同比增长117.36%
股市必读：智飞生物新发布《关于鼻喷重组呼吸道合胞病毒疫苗（黑猩猩腺病毒载体）获得临床试验批准通知书的公告》
证券之星 · 10-26
股市必读：智飞生物新发布《关于鼻喷重组呼吸道合胞病毒疫苗（黑猩猩腺病毒载体）获得临床试验批准通知书的公告》
智飞生物最新公告：鼻喷重组RSV疫苗获临床试验批准
证券之星 · 10-23
智飞生物最新公告：鼻喷重组RSV疫苗获临床试验批准
智飞生物（300122）披露关于变更签字注册会计师的公告，10月21日股价上涨1.92%
证券之星 · 10-21
智飞生物（300122）披露关于变更签字注册会计师的公告，10月21日股价上涨1.92%
股市必读：智飞生物新发布《关于首次回购公司股份暨回购股份进展的公告》
证券之星 · 10-19
股市必读：智飞生物新发布《关于首次回购公司股份暨回购股份进展的公告》
智飞生物：专一、专注、专业地在生物制药领域深耕
证券之星 · 10-16
智飞生物：专一、专注、专业地在生物制药领域深耕
智飞生物：重庆宸安聚焦糖尿病、肥胖等代谢类疾病领域
证券之星 · 10-16
智飞生物：重庆宸安聚焦糖尿病、肥胖等代谢类疾病领域
智飞生物最新公告：首次回购公司股份78.28万股
证券之星 · 10-16
智飞生物最新公告：首次回购公司股份78.28万股
智飞生物（300122）10月15日主力资金净卖出1495.06万元
证券之星 · 10-16
智飞生物（300122）10月15日主力资金净卖出1495.06万元
加载更多
公司概况
公司名称：
重庆智飞生物制品股份有限公司
所属行业：
医药制造业
上市日期：
2010-09-28
主营业务：
重庆智飞生物制品股份有限公司的主营业务是疫苗、生物制品研发、生产、销售、推广、配送及进出口。公司的主要产品是盟威克、盟纳康、喜菲贝、盟纳克、智克威得、宜卡、微卡、优威克、四价流感病毒裂解疫苗、流感病毒裂解疫苗、达舒宸、佳达修9、乐儿德、纽莫法、欣安立适。
发行价格：
37.98
{"stockData":{"symbol":"300122","market":"SZ","secType":"STK","nameCN":"智飞生物","latestPrice":14.55,"timestamp":1793928090000,"preClose":14.94,"halted":0,"volume":0,"delay":0,"changeRate":-0.0261,"floatShares":1414000000,"shares":2394000000,"eps":-5.8813,"marketStatus":"开盘竞价","change":-0.39,"latestTime":"11-06 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":14.55,"askSize":1121,"bidPrice":14.55,"bidSize":1121,"shortable":0,"etf":0,"ttmEps":-5.8813,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793928600000},"marketStatusCode":1,"adr":0,"adjPreClose":14.94,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":16.43,"lowLimit":13.45,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2393789747,"isCdr":false,"pbRate":2.36,"roa":"--","roe":"--","epsLYR":-6.1506,"committee":0.071251,"marketValue":34830000000,"turnoverRate":0,"status":1,"floatMarketCap":20578000000},"requestUrl":"/m/hq/s/300122","defaultTab":"news","newsList":[{"id":"2680874270","title":"智飞生物（300122）披露回购公司股份进展公告，11月03日股价上涨4.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680874270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680874270?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:57","pubTimestamp":1793703473,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，智飞生物报收于14.56元，较前一交易日上涨4.97%，最新总市值为348.54亿元。该股当日开盘13.82元，最高14.73元，最低13.72元，成交额达9.09亿元，换手率为4.44%。公司于近日披露《关于回购公司股份的进展公告》。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300036504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","300122","LU2148510915.USD","LU2580892862.HKD","BK0077","BK0046","LU2580892789.USD","LU1064130708.USD","BK0188","BK0196","LU1064131003.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680207590","title":"股市必读：智飞生物（300122）10月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680207590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680207590?lang=zh_cn&edition=full","pubTime":"2026-11-02 02:18","pubTimestamp":1793557091,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，智飞生物报收于13.49元，上涨4.74%，换手率3.69%，成交量52.22万手，成交额7.02亿元。谢谢董秘： 您好，截至2026年10月20日，公司普通股股东人数为118,679，谢谢！当日关注点交易信息汇总：10月30日主力资金净流入3720.7万元，占总成交额5.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU1064130708.USD","BK0239","300122","LU1328615791.USD","BK0077","LU2148510915.USD","LU2580892789.USD","BK0188","LU2580892862.HKD","BK0196","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679029637","title":"智飞生物：截至2026年10月20日，公司普通股股东人数为118,679","url":"https://stock-news.laohu8.com/highlight/detail?id=2679029637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679029637?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:09","pubTimestamp":1793351360,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截止2026年10月20日的股东户数是多少？谢谢智飞生物回复：您好，截至2026年10月20日，公司普通股股东人数为118,679，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000041908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300122","LU1328615791.USD","BK0046","LU2580892862.HKD","LU1064131003.USD","LU2580892789.USD","BK0188","LU1064130708.USD","LU2148510915.USD","BK0239","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679954982","title":"智飞生物：公司员工持股计划正常存续中","url":"https://stock-news.laohu8.com/highlight/detail?id=2679954982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679954982?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:06","pubTimestamp":1793351171,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，董秘，请问你们员工持股计划还在续存吗？ 他们有没有割肉离场？智飞生物回复：您好，公司员工持股计划由其管理委员会负责日常管理事宜，目前该计划正常存续中。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000041825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892789.USD","BK0046","BK0188","300122","BK0077","LU2148510915.USD","LU2580892862.HKD","LU1064131003.USD","LU1064130708.USD","BK0239","BK0196","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679994441","title":"智飞生物（300122）10月28日主力资金净卖出2643.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679994441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679994441?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:19","pubTimestamp":1793236752,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月28日收盘，智飞生物报收于12.99元，下跌1.59%，换手率1.63%，成交量22.99万手，成交额2.99亿元。10月28日的资金流向数据方面，主力资金净流出2643.16万元，占总成交额8.83%，游资资金净流入920.31万元，占总成交额3.07%，散户资金净流入1722.85万元，占总成交额5.75%。融券方面，融券卖出2800.0股，融券偿还1.03万股，融券余量19.14万股，融券余额248.69万元。智飞生物主营业务：疫苗、生物制品研发、生产、销售、配送及进出口。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900016183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0239","LU1064130708.USD","LU2580892789.USD","BK0077","LU2580892862.HKD","LU1328615791.USD","LU1064131003.USD","300122","BK0046","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678460724","title":"智飞生物（300122）2026年三季报简析：亏损收窄，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2678460724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678460724?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:33","pubTimestamp":1793190787,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期智飞生物发布2026年三季报。截至本报告期末，公司营业总收入65.39亿元，同比下降14.46%，归母净利润-6.83亿元，同比上升48.55%。本报告期智飞生物盈利能力上升，毛利率同比增幅12.73%，净利率同比增幅38.53%。公司旗下宸安生物研发的利拉鲁肽注射液于今年 7月获批上市，9月正式发货并完成全国首针注射，已投入临床使用。本文数据来源于智飞生物2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800047654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","LU2148510915.USD","LU2580892862.HKD","BK0239","LU2580892789.USD","BK0188","LU1064130708.USD","300122","BK0077","BK0196","LU1064131003.USD","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678438528","title":"智飞生物（300122）10月27日主力资金净买入1731.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678438528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678438528?lang=zh_cn&edition=full","pubTime":"2026-10-28 09:07","pubTimestamp":1793149658,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，智飞生物报收于13.2元，上涨1.15%，换手率2.28%，成交量32.31万手，成交额4.29亿元。10月27日的资金流向数据方面，主力资金净流入1731.82万元，占总成交额4.04%，游资资金净流出2365.78万元，占总成交额5.52%，散户资金净流入633.96万元，占总成交额1.48%。融券方面，融券卖出2100.0股，融券偿还3.74万股，融券余量19.89万股，融券余额262.61万元。智飞生物主营业务：疫苗、生物制品研发、生产、销售、配送及进出口。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800015092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","LU1064130708.USD","BK0046","LU2148510915.USD","BK0196","LU2580892862.HKD","LU2580892789.USD","300122","BK0239","BK0077","LU1064131003.USD","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678759941","title":"智飞生物(300122)10月9日股东户数12.32万户，较上期减少0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678759941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678759941?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:48","pubTimestamp":1793098127,"startTime":"0","endTime":"0","summary":"证券之星消息，近日智飞生物披露，截至2026年10月9日公司股东户数为12.32万户，较9月30日减少777.0户，减幅为0.63%。在生物制品行业个股中，智飞生物股东户数高于行业平均水平，截至10月9日，生物制品行业平均股东户数为3.67万户。根据统计，智飞生物2026年9月30日至2026年10月9日，主力资金净流入2540.18万元，游资资金净流入5911.09万元，散户资金净流出8451.27万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2148510915.USD","BK0188","300122","LU2580892789.USD","LU1064131003.USD","LU1328615791.USD","BK0239","LU2580892862.HKD","BK0077","BK0046","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678237120","title":"智飞生物最新公告：冻干人用狂犬病疫苗获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2678237120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678237120?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:06","pubTimestamp":1793095612,"startTime":"0","endTime":"0","summary":"智飞生物(300122.SZ)公告称，公司全资子公司智飞龙科马的冻干人用狂犬病疫苗(人二倍体细胞)获国家药监局出具的《药品注册证书》。该疫苗以人二倍体细胞为培养基质，接种后可预防狂犬病。此次获批将丰富公司成人疫苗矩阵，为拓展市场奠定基础。截至公告披露日，国内有3款同类产品获批上市。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700033528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","300122","LU2580892862.HKD","LU2580892789.USD","159646","LU1064130708.USD","LU1328615791.USD","LU2148510915.USD","BK0239","BK0046","LU1064131003.USD","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678971711","title":"智飞生物(300122.SZ)发布前三季度业绩，归母净亏损6.83亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678971711","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678971711?lang=zh_cn&edition=full","pubTime":"2026-10-27 00:07","pubTimestamp":1793030868,"startTime":"0","endTime":"0","summary":"智飞生物(300122.SZ)发布2026年三季度报告，前三季度，公司实现营业收入65.39亿元，同比下降14.46%。归属于上市公司股东净亏损6.83亿元。归属于上市公司股东的扣除非经常性损益净亏损6.87亿元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astockgonggao/agugonggao20.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astockgonggao/agugonggao20.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2580892862.HKD","300122","BK0196","LU2148510915.USD","LU1064131003.USD","LU1064130708.USD","BK0239","BK0046","LU2580892789.USD","BK0077","BK0188","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678643471","title":"智飞生物：Q3净利1.25亿元，同比增117.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678643471","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678643471?lang=zh_cn&edition=full","pubTime":"2026-10-26 18:22","pubTimestamp":1793010156,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0046","LU1064130708.USD","BK0077","BK0188","BK0239","LU1064131003.USD","LU2580892862.HKD","LU1328615791.USD","LU2148510915.USD","300122","BK0196","LU2580892789.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678516498","title":"智飞生物最新公告：第三季度净利润1.25亿元同比增长117.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678516498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678516498?lang=zh_cn&edition=full","pubTime":"2026-10-26 18:20","pubTimestamp":1793010045,"startTime":"0","endTime":"0","summary":"智飞生物(300122.SZ)公告称，第三季度营收为25.15亿元，同比下降7.40%；净利润为1.25亿元，同比增长117.36%。前三季度营收为65.39亿元，同比下降14.46%；净亏损为6.83亿元。注：公司Q3净利润1.25亿，Q2净利润-4.2亿，据此计算，Q3净利润环比扭亏为盈。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600025842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678139805","title":"股市必读：智飞生物新发布《关于鼻喷重组呼吸道合胞病毒疫苗（黑猩猩腺病毒载体）获得临床试验批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678139805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678139805?lang=zh_cn&edition=full","pubTime":"2026-10-26 03:55","pubTimestamp":1792958110,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，智飞生物报收于12.87元，上涨3.54%，换手率1.83%，成交量25.94万手，成交额3.27亿元。当日关注点交易信息汇总：10月23日主力资金净流入696.98万元，占总成交额2.13%。目前国内尚无呼吸道合胞病毒疫苗获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892862.HKD","300122","BK0196","LU2148510915.USD","LU1064131003.USD","LU1064130708.USD","159646","BK0239","BK0046","LU2580892789.USD","BK0077","BK0188","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677694089","title":"智飞生物最新公告：鼻喷重组RSV疫苗获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2677694089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677694089?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:36","pubTimestamp":1792748188,"startTime":"0","endTime":"0","summary":"智飞生物(300122.SZ)公告称，公司全资子公司智飞绿竹研发的鼻喷重组呼吸道合胞病毒疫苗获国家药监局临床试验批准，同意开展预防RSV感染相关疾病的临床试验。截至公告日，国内尚无RSV疫苗获批上市，该产品采用鼻喷黏膜免疫技术路径，有望为高危人群提供新型无创预防选择。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0077","LU1328615791.USD","BK0188","BK0046","300122","LU2580892789.USD","BK0239","159646","LU2580892862.HKD","LU2148510915.USD","LU1064130708.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677777746","title":"智飞生物（300122）披露关于变更签字注册会计师的公告，10月21日股价上涨1.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677777746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677777746?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:15","pubTimestamp":1792592123,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，智飞生物报收于12.74元，较前一交易日上涨1.92%，最新总市值为304.97亿元。智飞生物于2026年10月21日发布《关于变更签字注册会计师的公告》。变更后，签字注册会计师为沙晓田女士和张晓歌女士。张晓歌女士具备注册会计师资质，2026年开始为本公司提供审计服务，近三年未签署上市公司审计报告，无执业处罚记录，符合独立性要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","LU2580892862.HKD","LU2580892789.USD","BK0188","LU2148510915.USD","LU1064130708.USD","BK0196","LU1064131003.USD","BK0239","BK0077","LU1328615791.USD","300122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676578990","title":"股市必读：智飞生物新发布《关于首次回购公司股份暨回购股份进展的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676578990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676578990?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:30","pubTimestamp":1792344632,"startTime":"0","endTime":"0","summary":"公司公告汇总：智飞生物于10月16日首次回购股份782,800股，成交金额999.91万元。董秘： 您好，截至2026年10月9日，公司普通股股东人数为123,196，谢谢！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","LU1064130708.USD","300122","BK0239","BK0196","LU2580892789.USD","BK0077","LU2148510915.USD","LU2580892862.HKD","BK0046","LU1064131003.USD","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675989425","title":"智飞生物：专一、专注、专业地在生物制药领域深耕","url":"https://stock-news.laohu8.com/highlight/detail?id=2675989425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675989425?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:33","pubTimestamp":1792143205,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，公司维持上市公司的目的和意义是什么？智飞生物回复：您好，公司专一、专注、专业地在生物制药领域深耕，聚焦生产经营稳健发展，持续开展产品创新，巩固核心竞争力；优化市场营销策略，提升商业推广效能；同时完善治理体系，强化全过程质量管理，为企业长远发展奠定坚实基础。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600030035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300122","BK1610","BK0046","LU1328615791.USD","LU2580892862.HKD","LU1064131003.USD","LU2580892789.USD","BK0188","LU1064130708.USD","LU2148510915.USD","BK0239","03069","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675989435","title":"智飞生物：重庆宸安聚焦糖尿病、肥胖等代谢类疾病领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2675989435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675989435?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:30","pubTimestamp":1792143042,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司目前在创新药方面在研的管线有多少？涉及什么方向的？智飞生物回复：您好，公司通过北京智飞绿竹、安徽智飞龙科马、重庆宸安三大研产基地持续完善“预防&治疗”一体化布局。重庆宸安聚焦糖尿病、肥胖等代谢类疾病领域，围绕GLP-1类似物、胰岛素类似物等领域布局。同时，公司参股重庆智睿投资有限公司，积极布局大健康领域，促进前沿生物医药、先进生物技术的研发和产业化。公司的研发管线详情请您查阅公司的信息披露，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600029841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892789.USD","BK0239","LU1064130708.USD","LU2580892862.HKD","LU2148510915.USD","LU1328615791.USD","300122","BK0196","BK0077","LU1064131003.USD","BK0188","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675560739","title":"智飞生物最新公告：首次回购公司股份78.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675560739","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675560739?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:21","pubTimestamp":1792142482,"startTime":"0","endTime":"0","summary":"智飞生物(300122.SZ)公告称，公司于2026年7月20日审议通过回购方案，拟以自有或自筹资金回购股份用于股权激励或员工持股计划，回购金额不低于1.5亿元且不超过3亿元，回购价格不超18.22元/股。2026年10月16日，公司首次通过集中竞价方式回购股份78.28万股，占总股本0.0327%，成交总金额999.91万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600029199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1064131003.USD","LU2580892789.USD","LU1064130708.USD","BK0077","300122","LU1328615791.USD","BK0196","LU2580892862.HKD","BK0046","BK0188","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675551471","title":"智飞生物（300122）10月15日主力资金净卖出1495.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675551471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675551471?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:09","pubTimestamp":1792112968,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月15日收盘，智飞生物报收于12.69元，下跌0.47%，换手率1.74%，成交量24.54万手，成交额3.12亿元。10月15日的资金流向数据方面，主力资金净流出1495.06万元，占总成交额4.78%，游资资金净流入186.83万元，占总成交额0.6%，散户资金净流入1308.23万元，占总成交额4.19%。融券方面，融券卖出2900.0股，融券偿还1.42万股，融券余量20.57万股，融券余额261.1万元。智飞生物主营业务：疫苗、生物制品研发、生产、销售、配送及进出口。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","LU1064130708.USD","BK0077","BK0188","BK0239","LU1064131003.USD","LU2580892862.HKD","LU1328615791.USD","LU2148510915.USD","300122","BK0196","LU2580892789.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793928093302,"stockEarnings":[{"period":"1week","weight":0.1599},{"period":"1month","weight":0.0687},{"period":"3month","weight":0.1083},{"period":"6month","weight":-0.0343},{"period":"1year","weight":-0.2923},{"period":"ytd","weight":-0.2083}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆智飞生物制品股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"118679人(较上一季度减少3.67%)","perCapita":"11917股","listingDate":"2010-09-28","address":"重庆市两江新区庆云路1号50层","registeredCapital":"239378万元","survey":" 重庆智飞生物制品股份有限公司的主营业务是疫苗、生物制品研发、生产、销售、推广、配送及进出口。公司的主要产品是盟威克、盟纳康、喜菲贝、盟纳克、智克威得、宜卡、微卡、优威克、四价流感病毒裂解疫苗、流感病毒裂解疫苗、达舒宸、佳达修9、乐儿德、纽莫法、欣安立适。","listedPrice":37.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"智飞生物(300122)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供智飞生物(300122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"智飞生物,300122,智飞生物股票,智飞生物股票老虎,智飞生物股票老虎国际,智飞生物行情,智飞生物股票行情,智飞生物股价,智飞生物股市,智飞生物股票价格,智飞生物股票交易,智飞生物股票购买,智飞生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"智飞生物(300122)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供智飞生物(300122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}